Inhouse product
Indications
Perkirol is indicated
for the treatment of the signs and symptoms of idiopathic Parkinson's disease.
It is also indicated for the treatment of moderate-to-severe primary Restless
Legs Syndrome (RLS).
* রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন'
Pharmacology
Ropinirole is a
non-ergoline dopamine agonist. Ropinirole has the highest affinity at the D3
receptors, which are concentrated in the limbic areas of the brain and may be
responsible for some of the neuropsychiatric effects. The exact mechanism of
action of ropinirole as a treatment for Parkinson’s disease is unknown,
however, it is believed to be related to its ability to selectively stimulate
dopamine D2 receptors within the caudate-putamen system in the brain. This
system affects body movement. Negligible affinity is seen for ropinirole at α2
adrenoreceptors in the periphery and 5HT-1 receptor. Ropinirole has no affinity
at the D1-like receptors, benzodiazepine or GABA receptors. The precise
mechanism of action of ropinirole as a treatment for Restless Legs Syndrome is
unknown, however, it is believed to be related to its ability to stimulate
dopamine receptors.
Dosage & Administration
Dosing
for Parkinson's disease:
The recommended starting dose for Parkinson's disease is 0.25 mg three times
daily. Based on individual patient therapeutic response and tolerability, if
necessary, the dose should then be titrated with weekly increments as described
below. Maximum recommended total daily dose of 24 mg (8 mg three times daily).
Dosing
for Restless Legs Syndrome:
The recommended adult starting dose for RLS is 0.25 mg once daily 1 to 3 hours
before bedtime. After 2 days, if necessary, the dose can be increased to 0.5 mg
once daily, and to 1 mg once daily at the end of the first week of dosing, then
as shown below as needed to achieve efficacy. Titration should be based on
individual patient therapeutic response and tolerability, up to a maximum
recommended dose of 4 mg daily.
* রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন'
Interaction
Because Perkirol is a
dopamine agonist, it is possible that dopamine antagonists such as neuroleptics
(phenothiazines, butyrophenones, thioxanthenes) or metodopramide may reduce the
efficacy of Perkirol.
Contraindications
It is contraindicated
in patients known to have a hypersensitivity to Ropinirole.
Side Effects
The most common side
effects of Perkirol include fainting, drowsiness, hallucinations, dizziness,
nausea or vomiting, uncontrolled sudden movements, leg swelling, fatigue,
confusion, headache, upset stomach, abdominal pain or discomfort, increased
sweating etc.
Pregnancy & Lactation
Pregnancy category C.
There is no adequate and well-controlled studies in pregnant women. It should
be used during pregnancy only if the potential benefit outweighs the potential
risk to the fetus. Ropinirole inhibits prolactin secretion in human and could
potentially inhibit lactation.
Precautions & Warnings
Patients treated with
Perkirol have reported falling asleep while engaged in activities of daily
living. Dopamine agonists in clinical trials and clinical experience appear to
impair the systemic regulation of blood pressure, with resulting orthostatic
hypotension.
Therapeutic Class
Antiparkinson drugs
Storage Conditions
Protect from light and
moisture, store below 25°C. Keep out of the reach of children.
Login Or Registerto submit your questions to seller
No none asked to seller yet